KMDA Q1 2024 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$520M

Q1 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$38M+22.9% YoY

Gross Profit

$17M44.4% margin

Operating Income

$4M10.7% margin

Net Income

$2M6.3% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

+3.6%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

-$2M

Stock-Based Comp.

$241,000

Balance Sheet

Total Assets

$343M

Total Liabilities

$97M

Stockholders' Equity

$247M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$38M	$31M	+22.9%
Gross Profit	$17M	$12M	+41.5%
Operating Income	$4M	$289,000	+1297.6%
Net Income	$2M	-$2M	+230.7%